Growth Metrics

Enovis (ENOV) EBT (2016 - 2025)

Enovis (ENOV) has disclosed EBT for 16 consecutive years, with -$509.5 million as the latest value for Q4 2025.

  • Quarterly EBT rose 24.37% to -$509.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.2 billion through Dec 2025, down 40.89% year-over-year, with the annual reading at -$1.2 billion for FY2025, 40.89% down from the prior year.
  • EBT for Q4 2025 was -$509.5 million at Enovis, up from -$566.9 million in the prior quarter.
  • The five-year high for EBT was $116.4 million in Q3 2022, with the low at -$673.7 million in Q4 2024.
  • Average EBT over 5 years is -$105.3 million, with a median of -$28.7 million recorded in 2023.
  • The sharpest move saw EBT skyrocketed 401.46% in 2023, then plummeted 8898.82% in 2024.
  • Over 5 years, EBT stood at -$24.6 million in 2021, then surged by 89.66% to -$2.5 million in 2022, then surged by 401.46% to $7.7 million in 2023, then tumbled by 8898.82% to -$673.7 million in 2024, then rose by 24.37% to -$509.5 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$509.5 million, -$566.9 million, and -$25.7 million for Q4 2025, Q4 2025, and Q3 2025 respectively.